Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma

NCT01861912 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

258

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

DEVICE: Arsenic trioxide TACE
DRUG: Arsenic trioxide intravenous infusion
DRUG: lipiodol
DRUG: NaCl solution

Sponsor

Guangdong Provincial People's Hospital